In chronic lymphocytic leukemia (CLL), certain recurrent genetic alterations are known to influence disease progression and ...

In chronic lymphocytic leukemia (CLL), certain recurrent genetic alterations are known to influence disease progression and ...

Patients with chronic lymphocytic leukemia (CLL) who experience Richter transformation have a poor prognosis, but ibrutinib may help boost the efficacy of chimeric antigen receptor T-cell therapies.

Researchers sought to determine whether a pharmacist-led clinic for administering venetoclax would be effective for patients with CLL.

Ahmad Abuhelwa, MD, discusses the mechanisms of statins and how they can play a surprisingly beneficial role in patients with ...

For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival.

In January 2023, the Brukinsa, a next-generation BTK inhibitor, received FDA approval for chronic lymphocytic leukemia (CLL).

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

Participants in the CLL11 trial and a smaller group of patients followed after study completion showed improved overall ...

Research shows improved survival outcomes with statin use in patients with chronic lymphocytic leukemia receiving ibrutinib ...

Improvements seen in overall survival, progression-free survival, and cancer-specific survival. HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic ...